Pay in 4 interest-free payments of $6.99 Learn more
Ships within 48 hours · Estimated delivery Aug 26 - Aug 31
3 Clinical trial of flavonoids in liver diseases This is supported by Tehrani et al.s work demonstrating that soy isoflavones could significantly reduce triglyceride, low density lipoprotein, total cholesterol, waist circumference and hip circumference in NAFLD patients in a randomized clinical trial involving 50 patients with NAFLD (Neshatbini Tehrani et al., 2024)
Request a mAI Companion Demo: [email protected] maicompanion.ai #EndoscopicUltrasound #EUS #Gastroenterology #MedicalAI #ArtificialIntelligence #Endoscopy #MedTech #ClinicalWorkflow #DigitalHealth #MedicalTraining #InnovationInMedicine #MediGlobe To view or add a comment, sign in Here, Dr
As a pharmacologic therapeutic, optimizing the efficacy of GSH and minimizing its unintended effects means it is crucial to determine the correct timing, dose, and disease context (Schieber and Chandel, 2014)
Free, no credit card required
